<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="234642">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00018785</url>
  </required_header>
  <id_info>
    <org_study_id>IMMU-035-98S</org_study_id>
    <nct_id>NCT00018785</nct_id>
  </id_info>
  <brief_title>Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants</brief_title>
  <official_title>Living-Related Donor Bone Marrow Immunoregulation in Kidney Transplants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <brief_summary>
    <textblock>
      Diabetes and end-stage kidney, liver and heart disease are prominent health issues among
      veteran patients. Successful solid organ transplantation in the absence of chronic
      immunosuppressive therapy (specific acquired immunological tolerance) is a desirable
      therapeutic option. This project extends recent observations supporting the use of
      concommitant donor bone marrow cell infusion as a means of modulating the immune response in
      kidney transplantation, thereby allowing a substantial decrease or withdrawal of potentially
      toxic immunosuppressive drugs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1998</start_date>
  <completion_date>September 2003</completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <condition>Kidney Disease</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>donor bone marrow infusion</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Living related donor kidney transplant recipients and the living related donors.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Camillo Ricordi, M.D.</last_name>
  </overall_official>
  <overall_official>
    <last_name>Andreas Tzakis, M.D.</last_name>
  </overall_official>
  <overall_official>
    <last_name>Violet Esquenazi, Ph.D.</last_name>
  </overall_official>
  <overall_official>
    <last_name>Keith Zucker, Ph.D.</last_name>
  </overall_official>
  <location>
    <facility>
      <name>VAMC Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33125</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2004</verification_date>
  <lastchanged_date>January 20, 2009</lastchanged_date>
  <firstreceived_date>July 3, 2001</firstreceived_date>
  <keyword>kidney transplantation</keyword>
  <keyword>immunosuppression</keyword>
  <keyword>bone marrow</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
